All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to…

Recall #: D-1104-2023
Affected scope: Unknown
Initiated: August 14, 2023

Compiled from official public sources by the publisher. · Updated September 2026

Verify with FDA Drug →

View my saved recalls

Inmar Supply Chain Solutions, LLC recalled All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar. - a moderate-severity action.

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar. was recalled by Inmar Supply Chain Solutions, LLC in August 30, 2023. Reason: CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to u…. Check the official notice for the remedy. Verify recall #D-1104-2023 with the FDA Drug before acting.

The recall

Inmar Supply Chain Solutions, LLC issued this moderate-severity FDA Drug recall-CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to u….

Moderate
severity level: Class II
classification: August 30, 2023
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1104-2023 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Reason for recall

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Moderate (Class II)
Status	Ongoing
Recall number	D-1104-2023
Date reported	August 30, 2023
Date initiated	August 14, 2023
Recalling firm	Inmar Supply Chain Solutions, LLC
Firm location	Arlington, TX
Affected scope	Unknown
Distribution	Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-1104-2023) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.. Recalled by Inmar Supply Chain Solutions, LLC. Units affected: Unknown.

Why was this product recalled? ▼

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on August 30, 2023. Severity: Moderate. Recall number: D-1104-2023.

Where was the recalled product distributed? ▼

Distribution: Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown..

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Moderate), closest by report date among other firms and states.

Rufinamide Tablets, USP 200 mg, packaged … 2023-08-30 Rufinamide Tablets, USP 400 mg, packaged … 2023-08-30 Protex Foaming Hand Sanitizer (Benzalkoni… 2023-08-30 Helix Pain Relieving Cream (Menthol 7.4%)… 2023-08-30

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Moxifloxacin - Bromfenac Sterile Ophthalm… 2023-08-30 Blis-To-Sol Liquid (Tolnaftate), 1%, pack… 2023-08-30 YAGER'S LINIMENT (Camphor and Turpentine … 2023-08-30 ALCOLADO RELAMPAGO (Menthol and Camphor),… 2023-08-30

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported August 30, 2023. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026